Microfluidic nucleic acid analysis

US9579650B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9579650-B2
Application numberUS-201414494284-A
CountryUS
Kind codeB2
Filing dateSep 23, 2014
Priority dateOct 2, 2002
Publication dateFeb 28, 2017
Grant dateFeb 28, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Nucleic acid from cells and viruses sampled from a variety of environments may purified and expressed utilizing microfluidic techniques. In accordance with one embodiment of the present invention, individual or small groups of cells or viruses may be isolated in microfluidic chambers by dilution, sorting, and/or segmentation. The isolated cells or viruses may be lysed directly in the microfluidic chamber, and the resulting nucleic acid purified by exposure to affinity beads. Subsequent elution of the purified nucleic acid may be followed by ligation and cell transformation, all within the same microfluidic chip. In one specific application, cell isolation, lysis, and nucleic acid purification may be performed utilizing a highly parallelized microfluidic architecture to construct gDNA and cDNA libraries.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of preparing a plurality of cDNA libraries from single cells, comprising: obtaining a sample of cells; isolating a plurality of single cells from the sample within one or more channels of a microfluidic device such that single cells are fluidically isolated from each other; individually lysing at least some of the isolated single cells to liberate mRNA while keeping the mRNA from the single cells separate; reverse transcribing the mRNA liberated from the single cells isolated within the microfluidic device to form cDNA; and amplifying the cDNA, thereby obtaining the plurality of cDNA libraries from single cells. 2. A method of preparing a plurality of cDNA libraries from single cells, comprising: obtaining a sample of cells; isolating a plurality of single cells from the sample within one or more channels of a microfluidic device by segmentation; lysing at least some often isolated single cells to produce isolated mRNA such that mRNA from each individual cell remains together and is kept separate from mRNA from all other cells in the sample; and reverse transcribing and amplifying the mRNA from at least some of the single cells that were isolated within the microfluidic device to form cDNA, thereby obtaining the plurality of cDNA libraries from single cells. 3. The method of claim 1 , whereby mRNA from each individual cell remains together. 4. The method of claim 1 , further comprising performing a ligation reaction with the cDNA from the single cells. 5. The method of claim 1 or claim 2 , wherein amplifying comprises using different primers to amplify the cDNA from different isolated single cells. 6. The method of claim 2 , further comprising performing a ligation reaction with the cDNA from the single cells. 7. The method of claim 4 or claim 6 , wherein the ligation reaction comprises ligation to a host vector or plasmid. 8. The method of claim 4 or claim 6 , wherein ligated nucleic acid from the ligation reaction of the single cells is used to transform a host cell. 9. The method of any of claims 1 to 3 , wherein the plurality of single cells are fluidically isolated from each other and from other cells from the sample by closing a plurality of valves in the microfluidic device. 10. The method of claim 9 , whereby the plurality of single cells are fluidically isolated from each other in separate segments of the same channel. 11. The method of any of claims 1 to 3 , which includes determining an expression profile for the sample.

Assignees

Inventors

Classifications

  • characterised by the means or forces applied to move the fluids · CPC title

  • using resistive heater · CPC title

  • squeezing of channels or chambers · CPC title

  • Cards, e.g. flat sample carriers usually with flow in two horizontal directions · CPC title

  • characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9579650B2 cover?
Nucleic acid from cells and viruses sampled from a variety of environments may purified and expressed utilizing microfluidic techniques. In accordance with one embodiment of the present invention, individual or small groups of cells or viruses may be isolated in microfluidic chambers by dilution, sorting, and/or segmentation. The isolated cells or viruses may be lysed directly in the microfluid…
Who is the assignee on this patent?
California Inst Of Techn
What technology area does this patent fall under?
Primary CPC classification B01L3/50273. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).